Showing results (2031-2040 of 2,070) with videos related to
Sort By:
Pageof 207
Journal of Clinical Immunology|November 25, 2018
Transplantation of Hematopoietic Stem Cells for Primary Immunodeficiencies in Brazil: Challenges in Treating Rare Diseases in Developing CountriesJuliana Folloni Fernandes, Samantha Nichele, Liane E Daudt, et al.Hepatology (Baltimore, Md.)|February 11, 2025
Targeting protein hyper-SUMOylation halts cholangiocarcinoma progression by impairing cancer cell viability and tumor-stroma cross talkPaula Olaizola, Irene Olaizola, Marta Fernandez de Ara, et al.Human Genetics|December 23, 2024
Assessing the predicted impact of single amino acid substitutions in calmodulin for CAGI6 challengesPaola Turina, Giuditta Dal Cortivo, Carlos A Enriquez Sandoval, et al.Brazilian Journal of Medical and Biological Research = Revista Brasileira De Pesquisas Medicas E Biologicas|January 24, 2024
Assessing the reaction to and efficacy of the Screener drug discovery and development board game as a pedagogical tool in postgraduate coursesF Noël, G Xexéo, M A Martins, et al.Experimental Parasitology|June 25, 2025
Urine- and serum-based ELISA using a new recombinant chimeric protein to diagnose tegumentary and visceral leishmaniasis: a preliminary studyRaquel S B Câmara, Ana L Silva, Camila S Freitas, et al.The Science of the Total Environment|February 24, 2022
Prediction of enteric methane production and yield in dairy cattle using a Latin America and Caribbean databaseGuilhermo F S Congio, André Bannink, Olga L Mayorga, et al.Journal of Hepatology|May 5, 2025
New platinum derivatives selectively cause double-strand DNA breaks and death in naïve and cisplatin-resistant cholangiocarcinomasIrene Olaizola, Mikel Odriozola-Gimeno, Paula Olaizola, et al.Clinical Genetics|October 14, 2014
Collagen type IV-related nephropathies in Portugal: pathogenic COL4A5 mutations and clinical characterization of 22 familiesM J Nabais Sá, S Sampaio, A Oliveira, et al.ESMO Real World Data and Digital Oncology|February 6, 2026
The impact of targeted therapies on molecular alterations identified by an institutional molecular tumor board: an approach based on ESCAT classificationK Rahmani Narj Abadi, C Dupain, I Guillou, et al.Arthritis Research & Therapy|October 20, 2023
Commonalities and differences in set-up and data collection across European spondyloarthritis registries - results from the EuroSpA collaborationLouise Linde, Lykke M Ørnbjerg, Simon H Rasmussen, et al.Pageof 207